Investing in a Cure for Sickle Cell Disease: Lakshmanan Krishnamurti, M.D.

Watch this video to see Lakshmanan Krishnamurti, MD, discuss how NHLBI brings researchers together with the shared goal of improving quality of life for patients with sickle cell disease. This video is by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). Dr. Krishnamurti is Director of the Pediatric BMT Program at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta/Emory University. Learn more: https://www.nhlbi.nih.gov/health-topics/education-and-awareness/sickle-… Follow us on Twitter: http://www.twitter.com/nih_nhlbi Like us on Facebook: http://www.facebook.com/NHLBI

Science

National Heart, Lung, and Blood Institute

Website

https://www.nhlbi.nih.gov

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.

Core Mission Areas

The Science

Discover the goals, challenges, and initiatives that have shaped and will continue to shape prevention, diagnosis, and treatment for the NHLBI’s scientific focus areas.

Clinical Trials

NHLBI-funded clinical trials look at new ways to prevent, detect, or treat disease. The NHLBI is also focused on management and oversight of these trials.